Dr. Gil Rabinovici is a neurologist who cares for patients with memory problems and other brain health issues associated with commonly seen in older adults.

In research, Rabinovici investigates how to use advanced brain imaging techniques to improve the accuracy of dementia diagnoses and to better understand the biology of neurodegenerative diseases, with the overarching goal of accelerating drug development. He serves as director of the UCSF Alzheimer's Disease Research Center and as study chair for two large multicenter studies examining how PET amyloid scanning (a brain imaging technique) can improve the diagnosis and treatment of cognitive disorders causing memory changes.

He is also a principal investigator on several national projects to learn more about Alzheimer's disease and related disorders, including the Alzheimer’s Network for Treatment and Diagnostics (ALZ-NET), Longitudinal Evaluation of Alzheimer’s Disease Study (LEADS), ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI), and PI on several additional national and local clinical, imaging and translational studies focused on Alzheimer’s disease and related disorders. He has authored more than 280 peer-reviewed articles and is in the top 1% of most cited neuroscience scholars. His work is supported by the National Institutes of Health, Alzheimer's Association, American College of Radiology, Rainwater Charitable Foundation and industry partners.